These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 36969833)

  • 21. Non-vitamin K antagonist oral anticoagulants versus vitamin K antagonists in atrial fibrillation patients with previous stroke or intracranial hemorrhage: A systematic review and meta-analysis of observational studies.
    Guo Z; Ding X; Ye Z; Chen W; Chen Y
    Clin Cardiol; 2021 Jul; 44(7):917-924. PubMed ID: 34013988
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness and Safety of Antithrombotic Medication in Patients With Atrial Fibrillation and Intracranial Hemorrhage: Systematic Review and Meta-Analysis.
    Ivany E; Ritchie LA; Lip GYH; Lotto RR; Werring DJ; Lane DA
    Stroke; 2022 Oct; 53(10):3035-3046. PubMed ID: 35862238
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the Efficacy and Safety of Non-vitamin K Antagonist Oral Anticoagulants with Warfarin in Atrial Fibrillation Patients with a History of Bleeding: A Systematic Review and Meta-Analysis.
    Suah BH; Lee ZY; Teo YH; Teo YN; Syn NLX; Soh RYH; Yeo LLL; Tan BYQ; Ho JS; Li TYW; Lee CH; Chan MY; Yeo TC; Wong RCC; Chai P; Sia CH
    Am J Cardiovasc Drugs; 2022 Sep; 22(5):511-521. PubMed ID: 35292921
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anticoagulation medication in nontraumatic intracranial hemorrhage survivors with atrial fibrillation.
    Wang X; Wen D; Chen Y; You C; Ma L
    J Thromb Thrombolysis; 2023 Jul; 56(1):1-11. PubMed ID: 37022508
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness and Safety of DOACs vs. Warfarin in Patients With Atrial Fibrillation and Frailty: A Systematic Review and Meta-Analysis.
    Zeng S; Zheng Y; Jiang J; Ma J; Zhu W; Cai X
    Front Cardiovasc Med; 2022; 9():907197. PubMed ID: 35811719
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anticoagulant in atrial fibrillation patients with prior intracranial haemorrhage: a meta-analysis.
    Cai H; Chen G; Hu W; Jiang C
    Heart; 2023 Oct; 109(21):1594-1600. PubMed ID: 37321829
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Application of rivaroxaban in patients with non-valvular atrial fibrillation and end-stage kidney disease: A systematic review and meta-analysis.
    Yang Z; Wang J; Yuan Y; Cheng T; Ren F; Wang S; Zhang Z
    Front Cardiovasc Med; 2023; 10():1021959. PubMed ID: 36844734
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative effectiveness and safety of direct oral anticoagulants versus vitamin K antagonists in nonvalvular atrial fibrillation: a Canadian multicentre observational cohort study.
    Durand M; Schnitzer ME; Pang M; Carney G; Eltonsy S; Filion KB; Fisher A; Jun M; Kuo IF; Renoux C; Paterson JM; Quail J; Matteau A;
    CMAJ Open; 2020; 8(4):E877-E886. PubMed ID: 33355273
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Appropriate doses of non-vitamin K antagonist oral anticoagulants in high-risk subgroups with atrial fibrillation: Systematic review and meta-analysis.
    Kim IS; Kim HJ; Kim TH; Uhm JS; Joung B; Lee MH; Pak HN
    J Cardiol; 2018 Oct; 72(4):284-291. PubMed ID: 29706404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: A Systematic Review and Meta-Analysis.
    Pan KL; Singer DE; Ovbiagele B; Wu YL; Ahmed MA; Lee M
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28720644
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the Direct Oral Anticoagulants and Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Bitar YSL; Duraes AR; Roever L; Gomes Neto M; Lins-Kusterer L; Bocchi EA
    Front Cardiovasc Med; 2021; 8():712585. PubMed ID: 34631818
    [No Abstract]   [Full Text] [Related]  

  • 32. Intracranial hemorrhage among patients with atrial fibrillation anticoagulated with warfarin or rivaroxaban: the rivaroxaban once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation.
    Hankey GJ; Stevens SR; Piccini JP; Lokhnygina Y; Mahaffey KW; Halperin JL; Patel MR; Breithardt G; Singer DE; Becker RC; Berkowitz SD; Paolini JF; Nessel CC; Hacke W; Fox KA; Califf RM;
    Stroke; 2014 May; 45(5):1304-12. PubMed ID: 24743444
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and Safety of Renal Function on Edoxaban Versus Warfarin for Atrial Fibrillation: A Systematic Review and Meta-Analysis.
    Wang Y; Li L; Wei Z; Lu S; Liu W; Zhang J; Feng J; Wang D
    Medicines (Basel); 2023 Jan; 10(1):. PubMed ID: 36662497
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients with Atrial Fibrillation with Coronary or Peripheral Artery Disease.
    Zhang H; Xue Z; Yi D; Li X; Tan Y; Li J
    Int Heart J; 2020 Mar; 61(2):231-238. PubMed ID: 32173695
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral anticoagulants for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks.
    Aguilar MI; Hart R
    Cochrane Database Syst Rev; 2005 Jul; 2005(3):CD001927. PubMed ID: 16034869
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Direct Oral Anticoagulants (DOACs) are Non-Inferior to Vitamin K Antagonists for Patients Undergoing Transcatheter Aortic Valve Replacement with Indications of Anticoagulation.
    Wang J; Zhang FY; Liu L; Pan MM; Zhang C; Chen J; Bian Y; Lin HW; Gu ZC
    Rev Cardiovasc Med; 2022 Oct; 23(10):346. PubMed ID: 39077147
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and Safety of the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Concomitant Aspirin Therapy: A Meta-Analysis of Randomized Trials.
    Bennaghmouch N; de Veer AJWM; Bode K; Mahmoodi BK; Dewilde WJM; Lip GYH; Brueckmann M; Kleine E; Ten Berg JM
    Circulation; 2018 Mar; 137(11):1117-1129. PubMed ID: 29101289
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stroke prevention with direct oral anticoagulants in high-risk elderly atrial fibrillation patients at increased bleeding risk.
    Chao TF; Chan YH; Chiang CE; Tuan TC; Liao JN; Chen TJ; Lip GYH; Chen SA
    Eur Heart J Qual Care Clin Outcomes; 2022 Oct; 8(7):730-738. PubMed ID: 34694379
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.